冠状动脉CT血管造影用于多支冠状动脉疾病心脏团队决策
本研究将心脏团队随机分配,分别基于冠状动脉CTA或传统血管造影对左主干或三支冠状动脉病变患者评估,比较治疗决策一致性。结果显示两种影像策略的治疗决策一致性高(Cohen's kappa 0.82),FFRCT改变了7%患者的治疗决策。
要点
- 基于冠状动脉CTA的心脏团队治疗决策与传统血管造影决策高度一致(kappa 0.82)。
- FFRCT可用于部分病变并改变7%患者的治疗决策。
- 心脏团队在80%病例中就能否血运重建的冠状动脉节段达成一致。
核心结论
- 在左主干或三支冠状动脉病变患者中,基于冠状动脉CTA的心脏团队治疗决策与传统冠状动脉造影决策高度一致,提示仅基于该无创影像和临床信息进行决策与规划具有潜在可行性。
研究设计与样本
- 研究将由介入心脏病专家、心脏外科医生和放射科医生组成的不同心脏团队随机分配,分别使用冠状动脉CTA或传统血管造影评估新发左主干或三支冠状动脉病变。
- 共纳入223例患者。
- 主要终点为心脏团队之间血运重建策略的一致性;次要终点为FFRCT对治疗决策和手术规划的影响。
主要发现
- 基于冠状动脉CTA推荐CABG的比例为28%,基于传统血管造影为26%。
- 冠状动脉CTA与传统血管造影之间治疗决策的一致性高(Cohen's kappa 0.82,95%CI 0.74-0.91)。
- 心脏团队在80%的病例中就需血运重建的冠状动脉节段达成一致。
- FFRCT可用于869/1108个病变(196/223例患者),并在7%的患者中改变了治疗决策。
临床怎么用
- 对于左主干或三支冠状动脉病变患者,可考虑以冠状动脉CTA为基础由心脏团队进行血运重建决策与规划。
- FFRCT可辅助评估病变并可能影响部分患者的治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Coronary computed tomography angiography (CTA) has emerged as a non-invasive diagnostic method for patients with suspected coronary artery disease, but its usefulness in patients with complex coronary artery disease remains to be investigated. The present study sought to determine the agreement between separate heart teams on treatment decision-making based on either coronary CTA or conventional angiography. METHODS AND RESULTS: Separate heart teams composed of an interventional cardiologist, a cardiac surgeon, and a radiologist were randomized to assess the coronary artery disease with either coronary CTA or conventional angiography in patients with de novo left main or three-vessel coronary artery disease. Each heart team, blinded for the other imaging modality, quantified the anatomical complexity using the SYNTAX score and integrated clinical information using the SYNTAX Score II to provide a treatment recommendations based on mortality prediction at 4 years: coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or equipoise between CABG and PCI. The primary endpoint was the agreement between heart teams on the revascularization strategy. The secondary endpoint was the impact of fractional flow reserve derived from coronary CTA (FFRCT) on treatment decision and procedural planning. Overall, 223 patients were included. A treatment recommendation of CABG was made in 28% of the cases with coronary CTA and in 26% with conventional angiography. The agreement concerning treatment decision between coronary CTA and conventional angiography was high (Cohen's kappa 0.82, 95% confidence interval 0.74-0.91). The heart teams agreed on the coronary segments to be revascularized in 80% of the cases. FFRCT was available for 869/1108 lesions (196/223 patients). Fractional flow reserve derived from coronary CTA changed the treatment decision in 7% of the patients. CONCLUSION: In patients with left main or three-vessel coronary artery disease, a heart team treatment decision-making based on coronary CTA showed high agreement with the decision derived from conventional coronary angiography suggesting the potential feasibility of a treatment decision-making and planning based solely on this non-invasive imaging modality and clinical information. TRIAL REGISTRATION NUMBER: NCT02813473.
引用
- Collet C, Onuma Y, Andreini D, et al. Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease. Eur Heart J. 2018. PMID: 30312411. doi:10.1093/eurheartj/ehy581
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。